Author: Salam Amar Mohammad
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.12, Iss.5, 2003-05, pp. : 879-885
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Persistence with first-line antihypertensives poor in Italy
Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. :
Persistence with first-line antihypertensives poor in Italy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. :
Imatinib mesylate: best first-line pharmacotherapy for CML
Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. :
First-line voriconazole best option for invasive aspergillosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 538, 2007-01 ,pp. :
Human bocavirus: still more questions than answers
By Malecki Monika Schildgen Verena Schildgen Oliver
Future Virology, Vol. 6, Iss. 9, 2011-09 ,pp. :